White House Confident FDA Will Factor Innovation Into Diagnostic Oversight

A White House official expressed confidence FDA will develop a regulatory framework for genomic technologies that merges existing and evolving standards, and also spurs innovation while maximizing test accuracy. The official said the White House's close work with the agency will ensure the approach to regulation of diagnostics doesn't inhibit the innovation needed for the Precision Medicine Initiative to succeed while also protecting public health and safety. The remarks came as the administration announced next steps for President Barack Obama's...